List view / Grid view
NICE has approved palbociclib through the Cancer Drugs Fund, meaning…
NICE has approved palbociclib through the Cancer Drugs Fund, meaning that women with advanced breast cancer who have already received hormone therapy will now be eligible for palbociclib on the NHS.
Researchers believe the combination with established treatment could improve outcomes…
Researchers believe the combination with established treatment could improve outcomes in prostate cancer...
People who inherit genetic changes that alter the function of…
People who inherit genetic changes that alter the function of their immune system are at increased risk of developing Hodgkin lymphoma, according to new study by Institute of Cancer Research.
